메뉴 건너뛰기




Volumn 14, Issue 23, 2008, Pages 3650-3661

Partial overlap of anti-mycobacterial, and anti-Saccharomyces cerevisiae mannan antibodies in Crohn's disease

Author keywords

Anti mycobacterial antibodies; Anti Saccharomyces cerevisiae antibodies; Crohn's disease; Cross reactivity; Lipoarabinomannan; Mannan

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; AZATHIOPRINE; BACTERIUM ANTIBODY; FUNGUS ANTIBODY; IMMUNOGLOBULIN G; INFLIXIMAB; LIPOARABINOMANNAN; MANNAN BINDING LECTIN; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; MYCOBACTERIAL ANTIBODY; MYCOBACTERIUM ANTIGEN; SACCHAROMYCES CEREVISIAE MANNAN ANTIBODY; STEROID; TACROLIMUS; UNCLASSIFIED DRUG;

EID: 54349101022     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.3650     Document Type: Article
Times cited : (9)

References (46)
  • 1
    • 0029586031 scopus 로고
    • Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD)
    • Duchmann R, Kaiser L. Hermann E, Mayet W, Ewe K, Meyer zum Buschenfelde KH. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin Exp Immunol 1995; 102: 448-455
    • (1995) Clin Exp Immunol , vol.102 , pp. 448-455
    • Duchmann, R.1    Kaiser, L.2    Hermann, E.3    Mayet, W.4    Ewe, K.5    Meyer zum Buschenfelde, K.H.6
  • 2
    • 0038337828 scopus 로고    scopus 로고
    • Targeting enterk bacteria in treatment of inflammatory bowel diseases: Why, how, and when
    • Sartor RB. Targeting enterk bacteria in treatment of inflammatory bowel diseases: why, how, and when. Curr Opin Gastrointerol 2003; 19:358-365
    • (2003) Curr Opin Gastrointerol , vol.19 , pp. 358-365
    • Sartor, R.B.1
  • 3
    • 0042708022 scopus 로고    scopus 로고
    • Greenstein RJ. is Crohn's disease caused by a mycobacterium? Comparisons with leprosy, tuberculosis, and Johne's disease. Lancet Infect Dis 2003; 3: 507 514
    • Greenstein RJ. is Crohn's disease caused by a mycobacterium? Comparisons with leprosy, tuberculosis, and Johne's disease. Lancet Infect Dis 2003; 3: 507 514
  • 4
    • 10944261455 scopus 로고    scopus 로고
    • Serologic markers in inflammatory bowel disease: State of the art
    • Sandborn WJ. Serologic markers in inflammatory bowel disease: state of the art. Rev Gastroenterol Disord 2004; 4: 167-174
    • (2004) Rev Gastroenterol Disord , vol.4 , pp. 167-174
    • Sandborn, W.J.1
  • 7
    • 23944492085 scopus 로고    scopus 로고
    • ASCA: Genetic marker, predictor of disease, or marker of a response to an environmental antigen?
    • Seiboid F. ASCA: genetic marker, predictor of disease, or marker of a response to an environmental antigen? Gut 2005; 54: 1212-1213
    • (2005) Gut , vol.54 , pp. 1212-1213
    • Seiboid, F.1
  • 8
    • 0035120813 scopus 로고    scopus 로고
    • Anti-Saccharomyces cerevisiae antibodies in inflammatory bowel disease: A family study
    • Seibold F, Stich O, Hufnagl R, Kamil S, Scheurlen M. Anti-Saccharomyces cerevisiae antibodies in inflammatory bowel disease: a family study. Scand J Gastroenterol 2001; 36: 196-201.
    • (2001) Scand J Gastroenterol , vol.36 , pp. 196-201
    • Seibold, F.1    Stich, O.2    Hufnagl, R.3    Kamil, S.4    Scheurlen, M.5
  • 12
    • 36749049239 scopus 로고    scopus 로고
    • Anti-Saccharomyces cerevisiae marman antibodies (ASCA) of Crohn's patients crossreact with mannan from other yeast strains, and murine ASCA IgM can be experimentally induced with Candida albicans
    • Schaffer T, Muller S, Flogerzi B, Seibold-Schmid B, Schoepfer AM, Seibold F. Anti-Saccharomyces cerevisiae marman antibodies (ASCA) of Crohn's patients crossreact with mannan from other yeast strains, and murine ASCA IgM can be experimentally induced with Candida albicans. Inflamm Bowel Dis 2007, 13: 1339-1346
    • (2007) Inflamm Bowel Dis , vol.13 , pp. 1339-1346
    • Schaffer, T.1    Muller, S.2    Flogerzi, B.3    Seibold-Schmid, B.4    Schoepfer, A.M.5    Seibold, F.6
  • 14
    • 0031315805 scopus 로고
    • The mycobacterial cell wall: Structure, biosynthesis and sites of drug action
    • Chatterjee D. The mycobacterial cell wall: structure, biosynthesis and sites of drug action. Curr Opin Chem Biol 1990; 1: 579-588
    • (1990) Curr Opin Chem Biol , vol.1 , pp. 579-588
    • Chatterjee, D.1
  • 15
    • 0038175124 scopus 로고    scopus 로고
    • Lipoarabinomannans: From structure to biosynthesis
    • Nigou J, Gilleron M, Puzo G. Lipoarabinomannans: from structure to biosynthesis. Biochimie 2003; 85: 1153-1166
    • (2003) Biochimie , vol.85 , pp. 1153-1166
    • Nigou, J.1    Gilleron, M.2    Puzo, G.3
  • 16
    • 0024286486 scopus 로고
    • Binding properties of a mannose-specific lectin from the snowdrop (Galanthus nivalis) bulb
    • Shibuya N, Goldstein IJ, Van Damme EJ, Peumans WJ. Binding properties of a mannose-specific lectin from the snowdrop (Galanthus nivalis) bulb. J Biol Chem 1988; 263: 728-734
    • (1988) J Biol Chem , vol.263 , pp. 728-734
    • Shibuya, N.1    Goldstein, I.J.2    Van Damme, E.J.3    Peumans, W.J.4
  • 17
    • 0026170577 scopus 로고
    • interactions of five D-mannose-specific lectins with a series of synthetic branched trisaccharides
    • Kaku H, Goldstein IJ, Oscarson S. interactions of five D-mannose-specific lectins with a series of synthetic branched trisaccharides. Carbohydr Res 1991; 213; 109-116
    • (1991) Carbohydr Res , vol.213 , pp. 109-116
    • Kaku, H.1    Goldstein, I.J.2    Oscarson, S.3
  • 18
    • 0037163136 scopus 로고    scopus 로고
    • Structural study of lipomannan and lipoarabinomannan from Mycobacterium chelonae. Presence of unusual components with alpha 1,3-mannopyranose side chains
    • Guerardel Y, Maes E, Flass E, Leroy Y, Timmerman P, Besra GS, Locht C, Strecker G, Kremer L. Structural study of lipomannan and lipoarabinomannan from Mycobacterium chelonae. Presence of unusual components with alpha 1,3-mannopyranose side chains. J Biol Chem 2002; 277: 30635-30648
    • (2002) J Biol Chem , vol.277 , pp. 30635-30648
    • Guerardel, Y.1    Maes, E.2    Flass, E.3    Leroy, Y.4    Timmerman, P.5    Besra, G.S.6    Locht, C.7    Strecker, G.8    Kremer, L.9
  • 21
    • 0036712128 scopus 로고    scopus 로고
    • Seroreactivities against Saccharomyces cerevisiae and Mycobacterium avium subsp. paratuberculosis p35 and p36 antigens in Crohn's disease patients
    • Shafran I, Piromalli C, Decker JW, Sandoval J, Naser SA, EI-Zaatari FA. Seroreactivities against Saccharomyces cerevisiae and Mycobacterium avium subsp. paratuberculosis p35 and p36 antigens in Crohn's disease patients. Dig Dis Sci 2002; 47: 2079-2081
    • (2002) Dig Dis Sci , vol.47 , pp. 2079-2081
    • Shafran, I.1    Piromalli, C.2    Decker, J.W.3    Sandoval, J.4    Naser, S.A.5    EI-Zaatari, F.A.6
  • 22
    • 0034694984 scopus 로고    scopus 로고
    • Specific seroreactivity of Crohn's disease patients against p35 and p36 antigens of M. avium subsp. paratuberculosis
    • Naser SA, Hulten K, Shafran I, Graham DY, EI-Zaatari FA. Specific seroreactivity of Crohn's disease patients against p35 and p36 antigens of M. avium subsp. paratuberculosis. Vet Microbiol 2000; 77: 497-504
    • (2000) Vet Microbiol , vol.77 , pp. 497-504
    • Naser, S.A.1    Hulten, K.2    Shafran, I.3    Graham, D.Y.4    EI-Zaatari, F.A.5
  • 23
    • 0031720252 scopus 로고    scopus 로고
    • Mannose-Joinding lectin (MBL) in health and disease
    • Turner MW. Mannose-Joinding lectin (MBL) in health and disease. Immunobiology 1998; 199: 327-339
    • (1998) Immunobiology , vol.199 , pp. 327-339
    • Turner, M.W.1
  • 24
    • 0033052588 scopus 로고    scopus 로고
    • C-type lecthns and galecthns mediate innate and adaptive immune functions: Their roles in the complement activation pathway
    • Vasta GR, Quesenberry M, Ahmed H, O'Leary N. C-type lecthns and galecthns mediate innate and adaptive immune functions: their roles in the complement activation pathway. Dev Comp Immunol 1999; 23: 401-420
    • (1999) Dev Comp Immunol , vol.23 , pp. 401-420
    • Vasta, G.R.1    Quesenberry, M.2    Ahmed, H.3    O'Leary, N.4
  • 25
    • 0034999785 scopus 로고    scopus 로고
    • Mannose-binding lectin: Targeting the microbial world for complement attack and opsonophagocytosis
    • Jack DL, Klein NJ, Turner MW. Mannose-binding lectin: targeting the microbial world for complement attack and opsonophagocytosis. Immunol Rev 2001; 180: 86-99
    • (2001) Immunol Rev , vol.180 , pp. 86-99
    • Jack, D.L.1    Klein, N.J.2    Turner, M.W.3
  • 27
    • 5144227750 scopus 로고    scopus 로고
    • Genetic variants of the mannan-binding lectin are associated with immune reactivity to mannans in Crohn's disease
    • Seibold F, Konrad A, Flogerzi B, Seibold-Schmid B, Arni S, Juliger S, Kun JF. Genetic variants of the mannan-binding lectin are associated with immune reactivity to mannans in Crohn's disease. Gastroenterology 2004; 127: 1076-1084
    • (2004) Gastroenterology , vol.127 , pp. 1076-1084
    • Seibold, F.1    Konrad, A.2    Flogerzi, B.3    Seibold-Schmid, B.4    Arni, S.5    Juliger, S.6    Kun, J.F.7
  • 28
    • 33846006593 scopus 로고    scopus 로고
    • Deficiency for mannan-binding fectin is associated with antibodies to Saccharomyces cerevisiae in patients with Crohn's disease and their relatives
    • Seibold F, Boldt AB, Seibold-Schmid B, Schoepfer AM, Flogerzi B, Muller S, Kun JF. Deficiency for mannan-binding fectin is associated with antibodies to Saccharomyces cerevisiae in patients with Crohn's disease and their relatives. Gut 2007; 56: 152
    • (2007) Gut , vol.56 , pp. 152
    • Seibold, F.1    Boldt, A.B.2    Seibold-Schmid, B.3    Schoepfer, A.M.4    Flogerzi, B.5    Muller, S.6    Kun, J.F.7
  • 29
    • 0017227303 scopus 로고
    • Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study
    • Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976; 70: 439-444
    • (1976) Gastroenterology , vol.70 , pp. 439-444
    • Best, W.R.1    Becktel, J.M.2    Singleton, J.W.3    Kern Jr., F.4
  • 30
    • 0023521441 scopus 로고
    • Coated oral 3-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study
    • Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 3-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl I Med 1987; 317: 1625-1629
    • (1987) N Engl I Med , vol.317 , pp. 1625-1629
    • Schroeder, K.W.1    Tremaine, W.J.2    Ilstrup, D.M.3
  • 31
    • 33646778482 scopus 로고    scopus 로고
    • The Montreal classification of inflammatory bowel disease: Controversies, consensus, and implications
    • Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 2006; 55: 749-753
    • (2006) Gut , vol.55 , pp. 749-753
    • Satsangi, J.1    Silverberg, M.S.2    Vermeire, S.3    Colombel, J.F.4
  • 32
    • 0014634728 scopus 로고
    • Method for fingerprinting yeast cell wall mannans
    • Kocourek J, Ballou CE. Method for fingerprinting yeast cell wall mannans, J Bacteriol 1969; 100: 1175-1181
    • (1969) J Bacteriol , vol.100 , pp. 1175-1181
    • Kocourek, J.1    Ballou, C.E.2
  • 33
    • 0033805362 scopus 로고    scopus 로고
    • Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics
    • Vasiliauskas EA, Kam LY, Karp LC, Gaiennie J, Nam; H, Targan SR. Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics. Gut 2000; 47: 487-496
    • (2000) Gut , vol.47 , pp. 487-496
    • Vasiliauskas, E.A.1    Kam, L.Y.2    Karp, L.C.3    Gaiennie, J.4    Nam, H.5    Targan, S.R.6
  • 34
    • 34249313972 scopus 로고    scopus 로고
    • Antibodies to saccharomyces cerevisiae in Crohn's disease: Higher titers are associated with a greater frequency of mutant NOD2/CARD15 alleles and with a higher probability of complicated disease
    • Dassopoulos T, Frangakis C, Cruz-Correa M, Talor MV, Burek CL, Datta L, Nouvet F, Bayless TM, Brant SR. Antibodies to saccharomyces cerevisiae in Crohn's disease: higher titers are associated with a greater frequency of mutant NOD2/CARD15 alleles and with a higher probability of complicated disease. Inflamm Bowel Dis 2007; 13: 143-151
    • (2007) Inflamm Bowel Dis , vol.13 , pp. 143-151
    • Dassopoulos, T.1    Frangakis, C.2    Cruz-Correa, M.3    Talor, M.V.4    Burek, C.L.5    Datta, L.6    Nouvet, F.7    Bayless, T.M.8    Brant, S.R.9
  • 35
    • 3242698642 scopus 로고    scopus 로고
    • Anti-Saccharomyces cerevisiae antibody (ASCA) positivity is associated with increased risk for early surgery in Crohn's disease
    • Forcione DG, Rosen MJ, Kisiel JB, Sands BE. Anti-Saccharomyces cerevisiae antibody (ASCA) positivity is associated with increased risk for early surgery in Crohn's disease. Gut 2004; 53: 1117-1122
    • (2004) Gut , vol.53 , pp. 1117-1122
    • Forcione, D.G.1    Rosen, M.J.2    Kisiel, J.B.3    Sands, B.E.4
  • 36
    • 0035121977 scopus 로고    scopus 로고
    • Elevated antibody responses in patients with Crohn's disease against a 14-kDa secreted protein purified from Mycobacterium avium subsp. paratuberculosis
    • Olsen I, Wiker HG, Johnson E, Langeggen H, Reitan LJ. Elevated antibody responses in patients with Crohn's disease against a 14-kDa secreted protein purified from Mycobacterium avium subsp. paratuberculosis. Scand J Immunol 2001; 53: 198-203
    • (2001) Scand J Immunol , vol.53 , pp. 198-203
    • Olsen, I.1    Wiker, H.G.2    Johnson, E.3    Langeggen, H.4    Reitan, L.J.5
  • 37
    • 33745755063 scopus 로고    scopus 로고
    • Does cross-reactivity between mycobacterium avium paratuberculosis and human intestinal antigens characterize Crohn's disease?
    • Polymeros D, Bogdanos DP, Day R, Arioli D, Vergani D, Forbes A. Does cross-reactivity between mycobacterium avium paratuberculosis and human intestinal antigens characterize Crohn's disease? Gastroenterology 2006; 131: 85-96
    • (2006) Gastroenterology , vol.131 , pp. 85-96
    • Polymeros, D.1    Bogdanos, D.P.2    Day, R.3    Arioli, D.4    Vergani, D.5    Forbes, A.6
  • 38
    • 31844441031 scopus 로고    scopus 로고
    • Serologic markers in inflammatory bowel disease
    • Bossuyt X. Serologic markers in inflammatory bowel disease. Clin Chem 2006; 52: 17l-181
    • (2006) Clin Chem , vol.52
    • Bossuyt, X.1
  • 39
    • 4644276477 scopus 로고    scopus 로고
    • The glycan-rich outer layer of the cell wall of Mycobacterium tuberculosis acts as an antiphagocytic capsule limiting the association of the bacterium with macrophages
    • Stokes RW, Norris-Jones R, Brooks DE, Beveridge TJ, Doxsee D, Thorson LM. The glycan-rich outer layer of the cell wall of Mycobacterium tuberculosis acts as an antiphagocytic capsule limiting the association of the bacterium with macrophages. Infect Immun 2004; 72: 5676-5686
    • (2004) Infect Immun , vol.72 , pp. 5676-5686
    • Stokes, R.W.1    Norris-Jones, R.2    Brooks, D.E.3    Beveridge, T.J.4    Doxsee, D.5    Thorson, L.M.6
  • 40
    • 0026640822 scopus 로고
    • Lipoarabinomannan of Mycobacterium tuberculosis. Capping with mannosyl residues in some strains
    • Chatterjee D, Lowell K, Rivoire B, McNeil MR, Brennan PJ. Lipoarabinomannan of Mycobacterium tuberculosis. Capping with mannosyl residues in some strains. J Biol Chem 1992; 267: 6234-6239
    • (1992) J Biol Chem , vol.267 , pp. 6234-6239
    • Chatterjee, D.1    Lowell, K.2    Rivoire, B.3    McNeil, M.R.4    Brennan, P.J.5
  • 41
    • 0031951727 scopus 로고    scopus 로고
    • Mycobacterial lipoarabinomannan: An extraordinary lipoheteroglycan with profound physiological effects
    • Chatterjee D, Khoo KH. Mycobacterial lipoarabinomannan: an extraordinary lipoheteroglycan with profound physiological effects. Glycobiology 1998; 8: 113-120
    • (1998) Glycobiology , vol.8 , pp. 113-120
    • Chatterjee, D.1    Khoo, K.H.2
  • 42
    • 0001023242 scopus 로고    scopus 로고
    • Relationships between the structure and the roles ot lipoarabinomannans and related glycoconjugates in tuberculosis pathogenesis
    • Vercellone A, Nigou J, Puzo G. Relationships between the structure and the roles ot lipoarabinomannans and related glycoconjugates in tuberculosis pathogenesis. Front Biosci 1998; 3: e149-e163
    • (1998) Front Biosci , vol.3
    • Vercellone, A.1    Nigou, J.2    Puzo, G.3
  • 44
    • 30944451959 scopus 로고    scopus 로고
    • Mannose-binding lectin enhances the attachment and phagocytosis of mycobacteria in vitro
    • Bonar A, Chmiela M, Rudnicka W, Rozalska B. Mannose-binding lectin enhances the attachment and phagocytosis of mycobacteria in vitro. Arch Immunol Ther Exp (Warsz) 2005; 53: 437-441
    • (2005) Arch Immunol Ther Exp (Warsz) , vol.53 , pp. 437-441
    • Bonar, A.1    Chmiela, M.2    Rudnicka, W.3    Rozalska, B.4
  • 45
    • 34948873645 scopus 로고    scopus 로고
    • Cross-reactive epitopes on beta2-glycoprotein-I and Saccharomyces cerevisiae in patients with the antiphospliolipid syndrome
    • Krause I, Blank M, Cervera R, Font J, Matthias T, Pfeiffer S, Wies I, Fraser A, Shoenfeld Y. Cross-reactive epitopes on beta2-glycoprotein-I and Saccharomyces cerevisiae in patients with the antiphospliolipid syndrome. Ann N Y Acad Sci 2007; 1108: 481-488
    • (2007) Ann N Y Acad Sci , vol.1108 , pp. 481-488
    • Krause, I.1    Blank, M.2    Cervera, R.3    Font, J.4    Matthias, T.5    Pfeiffer, S.6    Wies, I.7    Fraser, A.8    Shoenfeld, Y.9
  • 46
    • 11144266571 scopus 로고    scopus 로고
    • Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype
    • Arnott ID, Landers CJ, Nimmo EJ, Drummond HE, Smith BK, Targan SR, Satsangi J. Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype. Am J Gastroenterol 2004; 99: 2376-2384
    • (2004) Am J Gastroenterol , vol.99 , pp. 2376-2384
    • Arnott, I.D.1    Landers, C.J.2    Nimmo, E.J.3    Drummond, H.E.4    Smith, B.K.5    Targan, S.R.6    Satsangi, J.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.